Folanovid 50 mg/300 mg/300 mg Fim-coated tablets
PDF Leaflet Revision Date: 29 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults aged 18 years and older.
Dosage (summary)
One tablet orally, once daily, without regard to food.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; potential risk of neural tube defects.
Key Drug Interactions
- Rifampicin decreases dolutegravir levels
- Avoid with dofetilide and pilsicainide
Contraindications
- Hypersensitivity to components
- Uncontrolled renal failure
- Pregnancy
- Lactation
- Moderate and severe hepatic impairment
Common side effects
- Nausea
- Diarrhoea
- Headache
- Rash
- Fatigue
Counselling Points
- Monitor for signs of lactic acidosis
- Use effective contraception in women of childbearing age
- Do not breastfeed while on FOLANOVID
Serious warnings
- Lactic acidosis and severe hepatomegaly
- Immune Reconstitution Inflammatory Syndrome (IRIS)
- Risk of opportunistic infections
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
